Karin Moelling

11.9k total citations · 2 hit papers
220 papers, 9.9k citations indexed

About

Karin Moelling is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Karin Moelling has authored 220 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Molecular Biology, 46 papers in Immunology and 37 papers in Genetics. Recurrent topics in Karin Moelling's work include HIV Research and Treatment (35 papers), Virus-based gene therapy research (29 papers) and HIV/AIDS drug development and treatment (24 papers). Karin Moelling is often cited by papers focused on HIV Research and Treatment (35 papers), Virus-based gene therapy research (29 papers) and HIV/AIDS drug development and treatment (24 papers). Karin Moelling collaborates with scholars based in Germany, Switzerland and United States. Karin Moelling's co-authors include Felix Broecker, Jovan Pavlovic, Christian Rommel, Gerald Radziwill, I. Greiser‐Wilke, Tobias Schulze, Peter Donner, Jeff Hansen, P. Beimling and Alexey A. Matskevich and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Karin Moelling

218 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)

1999 911 citations Karin Moelling et al. profile →
Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt

1999 670 citations Christian Rommel, Karin Moelling et al. profile →

Peers

Countries citing papers authored by Karin Moelling

Since Specialization

Citations

This map shows the geographic impact of Karin Moelling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Moelling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Moelling more than expected).

Fields of papers citing papers by Karin Moelling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Moelling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Moelling. The network helps show where Karin Moelling may publish in the future.

Co-authorship network of co-authors of Karin Moelling

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Moelling. A scholar is included among the top collaborators of Karin Moelling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Moelling. Karin Moelling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phage Therapy in Germany—Update 2023 2023 ·Viruses ·Christian Willy, Joachim J. Bugert, Annika Y. Claßen, Li Deng, (unknown), Justus Groß, Jens A. Hammerl, (unknown), C. Kühn, (unknown), Christine H. Rohde, Markus Rupp, Maria J. G. T. Vehreschild, Kilian Vogele, (unknown), Martin Witzenrath, Silvia Würstle, Holger Ziehr, Karin Moelling, Felix Broecker	25
2	Within-Host and Between-Host Evolution in SARS-CoV-2—New Variant’s Source 2021 ·Viruses ·Karin Moelling	18
3	Analysis of the Intestinal Microbiome of a Recovered <b><i>Clostridium difficile</i></b> Patient after Fecal Transplantation 2013 ·Digestion ·Felix Broecker, Michael Kube, Jochen Klumpp, Markus Schuppler, Luc Biedermann, Jochen Hecht, Michael Hombach, Peter M. Keller, Gerhard Rogler, Karin Moelling	29
4	A Short Hairpin Loop-Structured Oligodeoxynucleotide Targeting the Virion-Associated RNase H of HIV Inhibits HIV Production in Cell Culture and in huPBL-SCID Mice 2011 ·Intervirology ·Jochen Heinrich, Dominique Schols, Karin Moelling	5
5	Short hairpin-loop-structured oligodeoxynucleotides reduce HSV-1 replication 2009 ·Virology Journal ·(unknown), Jochen Heinrich, Karin Moelling	6
6	Akt‐ and Foxo1‐interacting WD‐repeat‐FYVE protein promotes adipogenesis 2008 ·The EMBO Journal ·Thorsten Fritzius, Karin Moelling	28
7	Heteromeric complex formation of ASK2 and ASK1 regulates stress-induced signaling 2007 ·Biochemical and Biophysical Research Communications ·(unknown), Karin Moelling	17
8	Short Partially Double-Stranded Oligodeoxynucleotide Induces Reverse Transcriptase/RNase H-Mediated Cleavage of HIV RNA and Contributes to Abrogation of Infectivity of Virions 2006 ·AIDS Research and Human Retroviruses ·Alexey A. Matskevich, Algirdas Ziogas, Jochen Heinrich, (unknown), Karin Moelling	18
9	An Improved Method for the Synthesis of Cellulose Membrane-Bound Peptides with Free C Termini Is Useful for PDZ Domain Binding Studies 2004 ·Chemistry & Biology ·Prisca Boisguérin, (unknown), Bernhard Aÿ, Gerald Radziwill, Karin Moelling, Liying Dong, Rudolf Volkmer	71
10	Cooperation of Ras‐ and c‐Myc–dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis 2004 ·Arthritis & Rheumatism ·(unknown), Michael Nawrath, Jochen Heinrich, Magnus Bosse, Anja Baier, Klaus M. Hummel, Peter Petrow, Stefan Kuchen, Beat A. Michel, Renate E. Gay, Ulf Müller‐Ladner, Karin Moelling, Steffen Gay	62
11	Intradermal Delivery of Interleukin-12 Plasmid DNA by in vivo Electroporation 2001 ·DNA and Cell Biology ·Richard Heller, Jan Schultz, M. L. Lucas, Mark J. Jaroszeski, Loreé C. Heller, Richard Gilbert, Karin Moelling, Claude Nicolau	60
12	The Combined Action of IL-15 and IL-12 Gene Transfer Can Induce Tumor Cell Rejection Without T and NK Cell Involvement 2000 ·The Journal of Immunology ·Emma Di Carlo, Alberto Comes, Stefania Basso, (unknown), Raffaella Meazza, Piero Musiani, Karin Moelling, Adriana Albini, Silvano Ferrini	63
13	Induction of putative tumor-suppressing genes in Rat-1 fibroblasts by oncogenic Raf-1 as evidenced by robot-assisted complex hybridization 2000 ·Journal of Molecular Medicine ·Joachim Heinrich, Magnus Bosse, (unknown), Wilfried Nietfeld, Richard Reinhardt, Hans Lehrach, Karin Moelling	10
14	p53 mutagenesis in klatskin tumors 1998 ·Human Pathology ·Sven Jonas, (unknown), R Tauber, Bertram Wiedenmann, H. Lobeck, (unknown), Bertolt Kreft, N. Kling, Karin Moelling, P. Neuhaus	11
15	Negative regulation of Raf activity by binding of 14-3-3 to the amino terminus of Raf in vivo 1997 ·Mechanisms of Development ·Christian Rommel, Gerald Radziwill, Karin Moelling, Ernst Hafen	43
16	p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells. 1996 ·Gut ·(unknown), Carsten Ziske, Bertram Wiedenmann, Karin Moelling	29
17	Conformational and Nucleic Acid Binding Studies on the Synthetic Nucleocapsid Protein of HIV-1 1993 ·Journal of Molecular Biology ·Andrej Surovoy, Jens Dannull, Karin Moelling, Günther Jung	55
18	Mutations within the RNase H Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Abolish Virus Infectivity 1991 ·Journal of General Virology ·Margaret Tisdale, Tobias Schulze, (unknown), Karin Moelling	129
19	Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybrids 1990 ·Biochemistry ·Birgitta M. Wöhrl, Karin Moelling	118
20	In vitro inhibition of HIV‐1 proteinase by cerulenin 1990 ·FEBS Letters ·Karin Moelling, Thomas G. Schulze, (unknown), John Kay, R A Jupp, (unknown), Laurence H. Pearl	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact